非アルコール性脂肪性肝炎の世界市場 2023-2027

非アルコール性脂肪性肝炎市場は2022-2027年に112億1,850万米ドル、予測期間中のCAGRは40.05％で成長すると予測されています。

当レポートでは、非アルコール性脂肪性肝炎市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。肥満とメタボリックシンドロームの有病率の上昇、世界の高齢化人口の増加、診断技術の進歩などが市場を牽引しています。

本調査では、今後数年間の非アルコール性脂肪性肝炎市場成長を牽引する主要因の1つとして、患者エンゲージメントと教育の高まりを挙げています。また、併用療法の出現とデジタルヘルスソリューションの統合は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 非アルコール性脂肪性肝炎の世界市場 2017-2021
• 流通チャネルセグメント分析 2017-2021
• 用途セグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• オフライン：市場規模と予測 2022-2027
• オンライン：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第7章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 診断：市場規模と予測 2022-2027
• 治療：市場規模と予測 2022-2027
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 市場機会：地域別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AstraZeneca Plc
• BioPredictive S.A.S
• Cirius Therapeutics
• Enzo Biochem Inc.
• GENFIT SA
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Intercept Pharmaceuticals Inc.
• Inventiva S.A.
• Madrigal Pharmaceuticals Inc.
• Novo Nordisk AS
• Prometheus Laboratories
• Siemens Healthineers AG
• Zydus Lifesciences Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global non-alcoholic steatohepatitis market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Online - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Distribution Channel ($ million)
• Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits44: Chart on Application - Market share 2022-2027 (%)
• Exhibits45: Data Table on Application - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on Diagnosis - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Diagnosis - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Diagnosis - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Diagnosis - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Treatment - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Treatment - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Treatment - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Treatment - Year-over-year growth 2022-2027 (%)
• Exhibits56: Market opportunity by Application ($ million)
• Exhibits57: Data Table on Market opportunity by Application ($ million)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share by geography 2022-2027 (%)
• Exhibits60: Data Table on Market share by geography 2022-2027 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits99: Market opportunity by geography ($ million)
• Exhibits100: Data Tables on Market opportunity by geography ($ million)
• Exhibits101: Impact of drivers and challenges in 2022 and 2027
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: AstraZeneca Plc - Overview
• Exhibits108: AstraZeneca Plc - Product / Service
• Exhibits109: AstraZeneca Plc - Key news
• Exhibits110: AstraZeneca Plc - Key offerings
• Exhibits111: BioPredictive S.A.S - Overview
• Exhibits112: BioPredictive S.A.S - Product / Service
• Exhibits113: BioPredictive S.A.S - Key offerings
• Exhibits114: Cirius Therapeutics - Overview
• Exhibits115: Cirius Therapeutics - Product / Service
• Exhibits116: Cirius Therapeutics - Key offerings
• Exhibits117: Enzo Biochem Inc. - Overview
• Exhibits118: Enzo Biochem Inc. - Product / Service
• Exhibits119: Enzo Biochem Inc. - Key offerings
• Exhibits120: GENFIT SA - Overview
• Exhibits121: GENFIT SA - Product / Service
• Exhibits122: GENFIT SA - Key offerings
• Exhibits123: Gilead Sciences Inc. - Overview
• Exhibits124: Gilead Sciences Inc. - Product / Service
• Exhibits125: Gilead Sciences Inc. - Key news
• Exhibits126: Gilead Sciences Inc. - Key offerings
• Exhibits127: GlaxoSmithKline Plc - Overview
• Exhibits128: GlaxoSmithKline Plc - Business segments
• Exhibits129: GlaxoSmithKline Plc - Key news
• Exhibits130: GlaxoSmithKline Plc - Key offerings
• Exhibits131: GlaxoSmithKline Plc - Segment focus
• Exhibits132: Intercept Pharmaceuticals Inc. - Overview
• Exhibits133: Intercept Pharmaceuticals Inc. - Product / Service
• Exhibits134: Intercept Pharmaceuticals Inc. - Key offerings
• Exhibits135: Inventiva S.A. - Overview
• Exhibits136: Inventiva S.A. - Product / Service
• Exhibits137: Inventiva S.A. - Key offerings
• Exhibits138: Madrigal Pharmaceuticals Inc. - Overview
• Exhibits139: Madrigal Pharmaceuticals Inc. - Product / Service
• Exhibits140: Madrigal Pharmaceuticals Inc. - Key offerings
• Exhibits141: Novo Nordisk AS - Overview
• Exhibits142: Novo Nordisk AS - Business segments
• Exhibits143: Novo Nordisk AS - Key offerings
• Exhibits144: Novo Nordisk AS - Segment focus
• Exhibits145: Prometheus Laboratories - Overview
• Exhibits146: Prometheus Laboratories - Product / Service
• Exhibits147: Prometheus Laboratories - Key offerings
• Exhibits148: Siemens Healthineers AG - Overview
• Exhibits149: Siemens Healthineers AG - Business segments
• Exhibits150: Siemens Healthineers AG - Key news
• Exhibits151: Siemens Healthineers AG - Key offerings
• Exhibits152: Siemens Healthineers AG - Segment focus
• Exhibits153: Zydus Lifesciences Ltd. - Overview
• Exhibits154: Zydus Lifesciences Ltd. - Business segments
• Exhibits155: Zydus Lifesciences Ltd. - Key offerings
• Exhibits156: Zydus Lifesciences Ltd. - Segment focus
• Exhibits157: Inclusions checklist
• Exhibits158: Exclusions checklist
• Exhibits159: Currency conversion rates for US$
• Exhibits160: Research methodology
• Exhibits161: Validation techniques employed for market sizing
• Exhibits162: Information sources
• Exhibits163: List of abbreviations

The non-alcoholic steatohepatitis market is forecasted to grow by USD 11,218.5 mn during 2022-2027, accelerating at a CAGR of 40.05% during the forecast period. The report on the non-alcoholic steatohepatitis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of obesity and metabolic syndrome, rise of global aging population, and advancements in diagnostic technologies.

Technavio's non-alcoholic steatohepatitis market is segmented as below:

By Distribution Channel

• Offline
• Online

By Application

• Diagnosis
• Treatment

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising patient engagement and education as one of the prime reasons driving the non-alcoholic steatohepatitis market growth during the next few years. Also, emergence of combination therapies and integration of digital health solutions will lead to sizable demand in the market.

The report on the non-alcoholic steatohepatitis market covers the following areas:

• Non-alcoholic steatohepatitis market sizing
• Non-alcoholic steatohepatitis market forecast
• Non-alcoholic steatohepatitis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-alcoholic steatohepatitis market vendors that include AstraZeneca Plc, BioPredictive S.A.S, Cirius Therapeutics, Enzo Biochem Inc., GENFIT SA, Gilead Sciences Inc., GlaxoSmithKline Plc, Inventiva S.A., Madrigal Pharmaceuticals Inc., Novo Nordisk AS, Prometheus Laboratories, Siemens Healthineers AG, Zydus Lifesciences Ltd., and Intercept Pharmaceuticals Inc. Also, the non-alcoholic steatohepatitis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global non-alcoholic steatohepatitis market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global non-alcoholic steatohepatitis market 2017 - 2021 ($ million)
• 4.2 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.3 Application Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Offline - Market size and forecast 2022-2027
• Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• 6.4 Online - Market size and forecast 2022-2027
• Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Distribution Channel
• Exhibit 42: Market opportunity by Distribution Channel ($ million)
• Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 44: Chart on Application - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
• 7.2 Comparison by Application
• Exhibit 46: Chart on Comparison by Application
• Exhibit 47: Data Table on Comparison by Application
• 7.3 Diagnosis - Market size and forecast 2022-2027
• Exhibit 48: Chart on Diagnosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Diagnosis - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Diagnosis - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Diagnosis - Year-over-year growth 2022-2027 (%)
• 7.4 Treatment - Market size and forecast 2022-2027
• Exhibit 52: Chart on Treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Treatment - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Application
• Exhibit 56: Market opportunity by Application ($ million)
• Exhibit 57: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share by geography 2022-2027 (%)
• Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 Canada - Market size and forecast 2022-2027
• Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 99: Market opportunity by geography ($ million)
• Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 AstraZeneca Plc
• Exhibit 107: AstraZeneca Plc - Overview
• Exhibit 108: AstraZeneca Plc - Product / Service
• Exhibit 109: AstraZeneca Plc - Key news
• Exhibit 110: AstraZeneca Plc - Key offerings
• 12.4 BioPredictive S.A.S
• Exhibit 111: BioPredictive S.A.S - Overview
• Exhibit 112: BioPredictive S.A.S - Product / Service
• Exhibit 113: BioPredictive S.A.S - Key offerings
• 12.5 Cirius Therapeutics
• Exhibit 114: Cirius Therapeutics - Overview
• Exhibit 115: Cirius Therapeutics - Product / Service
• Exhibit 116: Cirius Therapeutics - Key offerings
• 12.6 Enzo Biochem Inc.
• Exhibit 117: Enzo Biochem Inc. - Overview
• Exhibit 118: Enzo Biochem Inc. - Product / Service
• Exhibit 119: Enzo Biochem Inc. - Key offerings
• 12.7 GENFIT SA
• Exhibit 120: GENFIT SA - Overview
• Exhibit 121: GENFIT SA - Product / Service
• Exhibit 122: GENFIT SA - Key offerings
• 12.8 Gilead Sciences Inc.
• Exhibit 123: Gilead Sciences Inc. - Overview
• Exhibit 124: Gilead Sciences Inc. - Product / Service
• Exhibit 125: Gilead Sciences Inc. - Key news
• Exhibit 126: Gilead Sciences Inc. - Key offerings
• 12.9 GlaxoSmithKline Plc
• Exhibit 127: GlaxoSmithKline Plc - Overview
• Exhibit 128: GlaxoSmithKline Plc - Business segments
• Exhibit 129: GlaxoSmithKline Plc - Key news
• Exhibit 130: GlaxoSmithKline Plc - Key offerings
• Exhibit 131: GlaxoSmithKline Plc - Segment focus
• 12.10 Intercept Pharmaceuticals Inc.
• Exhibit 132: Intercept Pharmaceuticals Inc. - Overview
• Exhibit 133: Intercept Pharmaceuticals Inc. - Product / Service
• Exhibit 134: Intercept Pharmaceuticals Inc. - Key offerings
• 12.11 Inventiva S.A.
• Exhibit 135: Inventiva S.A. - Overview
• Exhibit 136: Inventiva S.A. - Product / Service
• Exhibit 137: Inventiva S.A. - Key offerings
• 12.12 Madrigal Pharmaceuticals Inc.
• Exhibit 138: Madrigal Pharmaceuticals Inc. - Overview
• Exhibit 139: Madrigal Pharmaceuticals Inc. - Product / Service
• Exhibit 140: Madrigal Pharmaceuticals Inc. - Key offerings
• 12.13 Novo Nordisk AS
• Exhibit 141: Novo Nordisk AS - Overview
• Exhibit 142: Novo Nordisk AS - Business segments
• Exhibit 143: Novo Nordisk AS - Key offerings
• Exhibit 144: Novo Nordisk AS - Segment focus
• 12.14 Prometheus Laboratories
• Exhibit 145: Prometheus Laboratories - Overview
• Exhibit 146: Prometheus Laboratories - Product / Service
• Exhibit 147: Prometheus Laboratories - Key offerings
• 12.15 Siemens Healthineers AG
• Exhibit 148: Siemens Healthineers AG - Overview
• Exhibit 149: Siemens Healthineers AG - Business segments
• Exhibit 150: Siemens Healthineers AG - Key news
• Exhibit 151: Siemens Healthineers AG - Key offerings
• Exhibit 152: Siemens Healthineers AG - Segment focus
• 12.16 Zydus Lifesciences Ltd.
• Exhibit 153: Zydus Lifesciences Ltd. - Overview
• Exhibit 154: Zydus Lifesciences Ltd. - Business segments
• Exhibit 155: Zydus Lifesciences Ltd. - Key offerings
• Exhibit 156: Zydus Lifesciences Ltd. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 157: Inclusions checklist
• Exhibit 158: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 159: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 160: Research methodology
• Exhibit 161: Validation techniques employed for market sizing
• Exhibit 162: Information sources
• 13.5 List of abbreviations
• Exhibit 163: List of abbreviations